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Abstract
Background: As we reported previously, Getah virus infection occurred in horses at the Miho training center of the
Japan Racing Association in 2014. This was the first outbreak after a 31-year absence in Japan. Here, we report a
recurrent outbreak of Getah virus infection in 2015, sequential to the 2014 one at the same site, and we summarize
its epizootiological aspects to estimate the risk of further outbreaks in upcoming years.
Results: The outbreak occurred from mid-August to late October 2015, affecting 30 racehorses with a prevalence of
1.5 % of the whole population (1992 horses). Twenty-seven (90.0 %) of the 30 affected horses were 2-year-olds, and
the prevalence in 2-year-olds (27/613 [4.4 %]) was significantly higher than that in horses aged 3 years or older
(3/1379 [0.2 %], P < 0.01). Therefore, the horses newly introduced from other areas at this age were susceptible,
whereas most horses aged 3 years or older, which had experienced the previous outbreak in 2014, were resistant.
Among the 2-year-olds, the prevalence in horses that had been vaccinated once (10/45 [22.2 %]) was significantly
higher than that in horses vaccinated twice or more (17/568 [3.0 %], P < 0.01). Horse anti-sera raised against an
isolate in 2014 neutralized both the homologous strain and a 2015 isolate at almost the same titers (256 to 512),
suggesting that these viruses were antigenically similar. Among horses entering the training center from private
surrounding farms in 2015, the seropositivity rate to Getah virus increased gradually (11.8 % in August, 21.7 % in
September, and 34.9 % in October). Thus, increased virus exposure due to the regional epizootic probably allowed
the virus to spread in the center, similarly to the outbreak in 2014.
Conclusions: The 2015 outbreak was caused by a virus which was antigenically close to the 2014 isolate, affecting
mostly 2-year-old susceptible horses under epizootiological circumstances similar to those in 2014. The existence of
2-year-olds introduced from regions free from Getah virus could continue to pose a potential risk of additional
outbreaks in upcoming years. Vaccination on private farms and breeding farms would help to minimize the risk of
outbreaks.
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Background
Getah virus is classified in the genus Alphavirus in the
family Togaviridae [1]. It is mosquito borne and is wide-
spread from Eurasia to Australasia. This virus causes
fever, generalized rash, and edema of the legs in horses
[1], and it causes fetal death and reproduction disorders
in pigs [2, 3].
We previously reported that an outbreak of Getah
virus infection occurred in racehorses at the Miho train-
ing center of the Japan Racing Association in autumn
2014, affecting 33 horses [4]. It was the first reported
outbreak of infection with this virus among vaccinated
horse populations worldwide, and the first one in Japan
since 1983 [5]. The indirect causes of this outbreak in-
cluded the existence of susceptible horses that did not
complete the vaccination program at the training center
and an increased risk of exposure because of epizootic
infection around the training center [6]. However, the
direct cause of the outbreak was still unclear, and the
epizootic pattern of this re-emerging virus in upcoming
years was unpredictable.
Following the outbreak in 2014, we took control mea-
sures to prevent a possible outbreak in the coming sea-
son. Measures included the reinforcement of pest
control for vector mosquitoes at the training center and
recommendations for Getah virus vaccination and pest
control on the private farms surrounding the center.
However, in 2015, another outbreak of Getah virus infec-
tion occurred at the Miho training center—the same site
as in 2014. Here, we summarize the epizootiological as-
pects of the current outbreak and analyze the antigenic
properties of the isolated virus to estimate the risk of
possible outbreaks in upcoming years.
Methods
Study site
The Miho training center is in Ibaraki Prefecture in the
Kanto region of Japan. About 2000 racehorses are
trained at the center, and about 1000 racehorses are re-
placed with new ones every month. The horses are gen-
erally accommodated at the center for 1 to 6 months for
training. After they leave the center they are usually kept
on other farms for several months for rest; they then re-
enter the center. The Japan Racing Association is the
sporting authority which administers the horses in the
training center, and the clinical samples were collected
as a part of regular activities for disease prevention. The
owners of racehorses have been notified that their horses
might be subjected to mandatory sampling of clinical
specimens for diagnostic and research purposes.
A two-dose priming course of Getah virus vaccine is
given to 2-year-olds. The vaccination period generally
starts in May and finishes in October to cover the mos-
quito season. Horses that are present at the training center
in spring receive the first dose in May and the second dose
in June. In the case of horses that enter after the mosquito
season has started, the first dose is administered when
they enter, and the second dose is given about 1 month
after the first. From the second season onward, the horses
are vaccinated annually before mosquito season.
Prevalence of Getah virus infection among populations
stratified by age and number of vaccine doses received
We investigated the age distribution and vaccination his-
tories of horses that were present at the Miho training
center on August 15, 2015, i.e. a few days before the out-
break started (n = 1992). On the basis of the number of
vaccination doses they had received before the outbreak,
horses in populations of each age were categorized into
two groups, namely 1) one dose; and 2) two doses or
more. The prevalence of disease onset of Getah virus in-
fection in each population during the period from
August 15 to October 30 2015 was calculated by divid-
ing the number of affected horses in each category by
the number of horses in the corresponding population.
The statistical significance of differences in prevalence
was evaluated by using Fisher’s exact test.
Cell culture
For virus isolation and virus-neutralizing (VN) testing, we
used Vero cells (Sumitomo Dainippon Pharma, Tokyo,
Japan). Cells were cultured in minimum essential medium
(MEM, MP Biomedicals, Irvine, CA, USA) containing 10 %
fetal calf serum (Sigma Aldrich Inc., St. Louis, MO, USA),
100 units/ml penicillin, and 100 μg/ml streptomycin (Sigma
Aldrich Inc.). MEM containing 2 % fetal calf serum, 100
units/ml penicillin, and 100 μg/ml streptomycin was used as
a maintenance medium for virus isolation and VN testing.
Detection of Getah virus RNA in blood samples of pyretic
horses at the Miho training center in 2015
Viral gene detection was performed in blood samples of
pyretic horses (≥38.5 °C) at the Miho training center. The
test period started in June 2015 and finished in mid-
November 2015. Viral RNA was extracted from EDTA-
treated blood samples by using a nucleic acid isolation kit
(MagNA Pure LC Total Nucleic Acid Isolation Kit, Roche
Diagnostics, Mannheim, Germany), and viral gene detec-
tion was performed by an RT-PCR for the Getah virus nsP1
gene using primer sets M2W-S and M3W-S [7]. For some
of the positive samples, the RT-PCR products (n = 7) were
sequenced as described previously [4].
VN test for Getah virus in paired sera collected from
pyretic horses at the Miho training center in 2015
From among 95 horses that developed pyrexia between
1 August and 30 October at the Miho training center,
we collected acute and convalescent sera (2- to 11-week
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intervals between paired sera collection) from 52. These
included 14 horses that were positive and 38 that were
negative on the above-mentioned Getah virus RT-PCR.
The sera were subjected to a VN test for Getah virus using
the 14-I-605 strain, which had been isolated from a race-
horse during the 2014 outbreak, as described previously
[6]. The VN test for Getah virus was performed as de-
scribed previously [6]. The VN titer was defined as the re-
ciprocal of the highest dilution that completely inhibited
virus growth. Horses that showed a ≥4-fold increase be-
tween the paired sera were defined as seroconverted.
Virus isolation
EDTA-treated blood samples collected from 23 horses that
had developed pyrexia and were positive on Getah virus
RT-PCR during the period from 18 August to 26
September 2015 were used for virus isolation. For some of
the 23 horses, buffy-coat specimens containing leukocytes
instead of whole blood were used for virus isolation. Getah
virus was isolated by using Vero cells as described previ-
ously [6]. Briefly, the samples were frozen and thawed three
times and then centrifuged at 800 g for 20 min at 4 °C. The
supernatants were inoculated onto 1-day monolayer cul-
tures of Vero cells or inoculated with the Vero cells simul-
taneously. The next day, the cells were washed three times
with phosphate-buffered saline (pH 7.2) and cultured in
maintenance medium. To identify Getah virus–specific nu-
cleotide sequences, the supernatants of specimens that
showed cytopathic effects were tested by RT-PCR for the
nsP1 gene, as described above.
Antigenic comparison of the vaccine strain and Getah
virus strains isolated in 2014 and 2015
Cross-neutralizing tests between the strain isolated in 2014
(14-I-605), the strain isolated in 2015, and the vaccine
strain (MI-110) were performed. Horse anti-sera that were
raised against the MI-110 strain (n = 2) and 14-I-605 strain
(n = 2) and prepared in our previous study were used [8].
VN tests were performed as described above.
Investigation of Getah virus epizootic infection among
horses on surrounding farms in Ibaraki and Chiba
prefectures
Among horses that were introduced into the Miho train-
ing center between June and October 2015, those that
met all of the following criteria (n = 51 to 81 in each
month) were tested: 1) 2 years old; 2) transferred from a
farm in Ibaraki Prefecture or the neighboring Chiba
Prefecture; and 3) no history of vaccination with inacti-
vated Getah virus vaccine. Sera collected on the day each
horse entered the Miho training center were subjected
to VN testing for Getah virus.
Results
Detection of Getah virus infection among pyretic horses
at the Miho training center in 2015
The numbers of pyretic horses each week at the Miho
training center are shown in Fig. 1. During the period
from June to mid-August, there were 4 to 9 pyretic
horses each week. These numbers increased to 10 or
more in all of the weeks except one from late August to
early October, and thereafter decreased to the earlier
baseline. Out of 171 pyretic horses in the whole period,
162 were tested for Getah virus by RT-PCR, and 29 of
them were positive. The first and last samples that were
positive by RT-PCR were collected from pyretic horses
on 18 August and 30 October, respectively (Fig. 1). We
collected paired sera from 14 of the 29 RT-PCR-positive
horses and subjected them to VN testing for Getah
virus; all of them had seroconverted (≥4-fold increase).
Fig. 1 Numbers of pyretic horses and Getah virus–infected horses at the Miho training center. Bars indicated the number of pyretic horses each week
from 1 June to 15 November. Black, number of horses positive on RT-PCR for Getah virus or seroconverted to Getah virus on VN testing, or both
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Paired sera collected from 38 RT-PCR-negative horses
that had developed pyrexia between 18 August and 30
October were also tested for VN antibodies; one horse,
which had developed pyrexia on 25 August, showed
seroconversion. In total, from among the 95 horses that
developed pyrexia between 18 August and 30 October,
30 were positive for Getah virus infection by RT-PCR or
VN testing, or both (Fig. 1). Among the 30 affected
horses, seven (23.3 %) had edema of their legs, and three
(10.0 %) had body rashes, but all of them recovered
within a few days. Two-year-olds accounted for 27
(90.0 %) of the 30 affected horses; the remainder con-
sisted of two 3-year-olds (two horses) and one 7-year-
old. Of the affected 2-year-olds, 10 had been vaccinated
only once before disease onset, and 17 had been vacci-
nated twice. All of the affected horses aged 3 years or
older had been vaccinated at least twice.
Prevalence of Getah virus infection among populations
stratified by age and number of vaccine doses received
We investigated the age distribution and vaccination histor-
ies of the whole horse population at the Miho training cen-
ter on August 15, 2015, i.e. a few days before the outbreak
started (Table 1). All horses (n = 1992) had been vaccinated
at least once before the outbreak. Among the 2-year-olds
(n = 613), 568 (92.7 %) had been vaccinated twice or more,
and the remaining 45 (7.3 %) had been vaccinated only
once (Table 1). Among the 3-year-olds (n = 794), 4-year-
olds (n =314) and 5-year-olds or older (n = 271), almost all
horses had been vaccinated two times or more (788
[99.2 %], 312 [99.4 %] and 271 [100.0 %], respectively,
Table 1).
The prevalence of Getah virus infection in the whole
population during the outbreak was 30/1992 (1.5 %). The
prevalence in 2-year-olds (27/613 [4.4 %]) was significantly
higher than that in horses aged 3 years or older (3/1379
[0.2 %], P < 0.01). Among the 2-year-olds, the prevalence
in horses that had been vaccinated once was 10/45
(22.2 %); this was significantly higher than that in horses
vaccinated twice or more (17/568 [3.0 %], P < 0.01).
Virus isolation and analysis of nucleic acid sequence
We tried to isolate Getah virus from blood samples that
were positive on RT-PCR. In testing on 23 blood sam-
ples, primary cocultivation resulted in the isolation of
two strains confirmed as Getah virus by RT-PCR. We
analyzed the sequences of the nsP1 genes of the two
strains and those of the RT-PCR products amplified
from some of the clinical samples (n = 7). All of the sam-
ples analyzed had completely identical nucleic acid se-
quences, and the sequences were also identical to that of
the 14-I-605 strain (381 bases, GenBank/EMBL/DDBJ
accession number, LC012885) isolated during the 2014
outbreak [6]. From this result, we used one of the two
2015 isolates (15-I-752) for the further studies.
Antigenic comparison of the vaccine strain and the 2014
and 2015 Getah virus strains
To assess whether the current Getah virus vaccine was
effective against the circulating virus in 2015, we per-
formed cross-neutralization tests between the vaccine
strain (MI-110) and the strains isolated in 2014 (14-I-
605) and 2015 (15-I-752). The results of the cross-
neutralization tests are summarized in Table 2. Our pre-
vious report revealed that horse sera (n = 2) raised
against MI-110 neutralized the homologous virus at ti-
ters of 512 and neutralized the 14-I-605 strain at almost
the same titers (256) [8]. In the current experiment, the
same set of sera neutralized the 15-I-752 strain at titers
of 256 (Table 2). The horse sera (n = 2) raised against
the 14-I-605 strain—which were also used in the previ-
ous study [8]—neutralized the homologous virus at a
titer of 256 or 512 and neutralized the 15-I-752 strain at
titers of 512 (Table 2). These results indicated that the
two strains isolated in 2014 and 2015 were antigenically
close to each other, and that the current vaccine con-
taining the MI-110 strain was likely sufficiently effective
against the circulating viruses.
Investigation of Getah virus epizootic infection among
horses on surrounding farms in Ibaraki and Chiba
prefectures
During the 2014 outbreak, we found that epizootic
Getah virus infection occurred not only at the training
Table 1 Numbers (%) of horses that had received Getah virus
vaccine and were being kept at the Miho training center on
August 15 in 2015
Vaccination dose Total
Age One Two or more
2 45 (7.3) 568 (92.7) 613
3 6 (0.8) 794 (99.2) 794
4 2 (0.6) 312 (99.4) 314
5 or older 0 (0.0) 271 (100.0) 271
Total 53 (2.7) 1,939 (97.3) 1,992
Table 2 Virus-neutralizing titers of sera from horses inoculated
with Getah virus MI-110 or 14-I-605 strain
Strain used in virus-neutralization test
Inoculated strain Horse MI-110 14-I-605 15-I-752
MI-110 1 512a 256a 256
2 512a 256a 256
14-I-605 3 512a 256a 512
4 1024a 512a 512
aData quoted from our previous study [8]
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center but also on private farms surrounding the center
[6]. To assess whether this regional epizootic had also
occurred in the 2015 outbreak, we calculated seroposi-
tivity rates among horses entering the center from farms
in Ibaraki Prefecture and the neighboring Chiba Prefec-
ture each month in 2015. The horses were 2-year-olds
with no history of Getah virus vaccination. Seropositivity
rates in June (5.5 %) and July (4.9 %) were comparable to
those in 2014 (Fig. 2) [6]. An increase in seropositivity was
observed in August (11.8 %), and those in September and
October were 21.7 and 34.9 %, respectively (Fig. 2), indi-
cating that Getah virus was epizootic in the area in
autumn 2015, similarly to the 2014 season.
Discussion
The epizootic Getah virus infection in 2015 seems to
have started earlier than that in 2014, which started in
mid-September [4]. This trend was observed both at the
Miho training center and on the private farms (Figs. 1
and 2). Despite the early start, the prevalence of Getah
virus infection in whole population at the training center
in 2015 (30/1992 [1.5 %]) was comparable to that in
2014 (33/1950 [1.7 %]) [4], suggesting that although the
epizootic in 2015 started earlier than that in 2014 it pro-
gressed more slowly. In support of this finding, the sero-
positivity rate in horses entering the center was lower in
October 2015 (34.9 %) than in October 2014 (42.9 %,
Fig. 2). We found that the age proportions of the horses
affected in 2014 and 2015 differed greatly; this might
have explained the relatively slow mild progression of
the 2015 outbreak. The proportion of 2-year-olds among
the horses affected in 2014 was 60.6 % [6], whereas that
in 2015 was 90.0 %, suggesting that horses aged 3 years
or older were relatively resistant to infection. This was
probably due to the fact that, because of the 2014 out-
break, many horses aged 3 years or older in 2015 had
already been exposed to Getah virus at the center or on
the private farms. Therefore, the existence of these re-
sistant horses might have delayed virus spread in the
horse population to some extent.
The significantly higher prevalence in the 2-year-olds
(4.4 %) than that in the 3-year-olds or older population
(0.2 %) was one of the most characteristic aspects of the
current outbreak, because such significant difference
was not observed in the 2014 outbreak [6]. In this re-
gard, even though older horses at the training center be-
come resistant after natural infection, we are still
concerned about the possibility of outbreaks of Getah
virus infection in upcoming years. In Japan, more than
95 % of racehorses are bred in Hokkaido Prefecture, in
northern Japan, and 2-year-olds are introduced to the
training center every year. At the time of introduction,
most have not been infected with Getah virus or vacci-
nated with Getah virus vaccine. Serological surveillance
also suggests that there is a low prevalence of Getah virus
infection in Hokkaido, with seropositivity rates of 0 %
among unvaccinated horses transferred out of Hokkaido
in 2013 and 2014 (Bannai et al., unpublished data). There-
fore, the existence of newly introduced 2-year-olds could
continue to pose a risk of additional outbreaks.
More than 30 private farms are located in Ibaraki Pre-
fecture, where the Miho training center stands, and in
neighboring Chiba Prefecture, and horses are repeatedly
transferred between the farms and the center for train-
ing and rest. Unlike in the training centers, where Getah
virus vaccination is mandatory, on the farms vaccination
is not common. In addition, this area is one of the big-
gest producers of pigs. Although the exact prevalence of
Getah virus in pigs and its association with the recent
outbreaks in horses have not been studied, the horses in
this area are considered to be at high risk of infection.
As in the 2014 outbreak, in 2015 our results indicated
that there was a high prevalence of Getah virus infection
among horses on the private farms (Fig. 2). This regional
epizootic probably resulted in an increased risk of virus
exposure and allowed the virus to spread in the center.
Therefore, the 2015 outbreak seems to have occurred
under epizootiological circumstances similar to those in
2014. It will be helpful to increase vaccination coverage
on private farms to prevent regional virus circulation.
Unfortunately, despite our recommendation, coverage
on the farms in 2015 seemed to be as low as in previous
years, although exact data were not available. In support
Fig. 2 Rates of seropositivity to Getah virus in horses transferred
from farms surrounding the Miho training center. Sera were
collected from horses introduced to the Miho training center
between June to October in 2014 or 2015. The horses (n = 51 to 81
in each month) were 2-year-olds that had been transferred from Ibaraki
or Chiba prefecture and had no history of Getah virus vaccination. Sera
were subjected to VN testing using the 14-I-605 strain. Data for 2014
are quoted from our previous report [6]
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of this speculation, among the 2-year-olds at the Miho
training center in mid-September 2015, the proportion
of those that had been vaccinated only once for Getah
virus was 9.0 % (75/831 head); this was almost the same
as that in 2014 (8.3 % [71/858 head]) [6]. The existence
of horses in this category reflects the low vaccination
coverage on the private farms, because horses with no
history of Getah virus vaccination are given their first,
priming, dose on entry to the training center. Among
the horses affected in the 2015 outbreak, 33.3 % (10/30
head) had been vaccinated only once before disease on-
set; this was comparable to the level in 2014 (30.3 %
[10/33 head]) [6], suggesting that these horses were
highly susceptible and were involved in spread of the
virus at the center, similarly to the situation in 2014.
The higher prevalence in 2-year-old horses vaccinated
only once (22.2 %) than that in those vaccinated twice or
more (3.0 %) also suggested the requirement of two-
doses priming vaccination for the protection of individ-
ual horses. Therefore, further efforts are needed to in-
crease vaccination coverage on the farms.
As described above, the 2014 and 2015 outbreaks of
Getah virus infection occurred after an absence of de-
tectable outbreaks for more than three decades. The
sudden outbreaks in the two sequential years at the
same site suggest the occurrence of direct factors such
as mutations that might alter the features of the virus.
Although we were initially concerned about antigenic
mismatch between the circulating virus and the vaccine
strain, our previous and current results suggest that the
2014 and 2015 isolates are antigenically similar to the
vaccine strain (Table 2) [8]. Other viral features which
may influence the epizootic includes the vector specifi-
city and the efficacy of replication in mosquitoes, be-
cause Getah virus is a typical mosquito-borne virus. A
previous ecological surveillance in 1979 at the Miho
training center revealed that Getah virus was isolated
from Aedes vexans nipponii and Culex tritaenior-
hynchus, and these two species were considered to be in-
volved in the circulation of Getah virus in Japan [9]. In
our previous study, we compared the full-genome se-
quences of the isolate in 2014 and the vaccine strain,
and found that non-structural protein 3 (nsP3) included
7 amino acid substitutions while the other non-
structural proteins had only 1 or 2 substitutions [8]. The
carboxyl-terminus domain of nsP3 was reported to be
involved in viral replication of genus Alphaviruses to
which Getah virus belongs [10], and also reported to be
a determinant of vector specificity in O’nyoug nyong
virus [11]. In this regard, further study on the mutations
in the nsP3 protein might provide clues to the causes of
the current outbreaks. In addition, investigation of the
density of vector species in the region surrounding the
training center, the prevalence of Getah virus in the
mosquitoes, and the epizootic situation in pigs, the nat-
ural host, would help us to understand the risk of future
outbreaks in horses.
Conclusions
In conclusion, an outbreak of Getah virus infection oc-
curred at the Miho training center in 30 horses from
mid-August to late October 2015. It was sequential to
the 2014 outbreak at the same site. The 2015 outbreak
was caused by a virus closely related to the 2014 isolate
and affected mostly 2-year-old susceptible horses under
epizootiological circumstances similar to those in 2014.
The existence of 2-year-olds introduced from non-
epizootic regions could continue to pose a risk of add-
itional outbreaks in upcoming years. Vaccination on pri-
vate farms and breeding farms would help to minimize
the risk of outbreaks. Continuous surveillance at the
training center, as well on the farms surrounding the
center, will be required.
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